Introduction arrest 7, 10 to apoptosis 11, 12 or differentiation [13] [14] [15] have been One of the critical steps in tumor gene therapy with described, making the wt-p53 gene a promising tool for tumor-suppressing agents (eg toxins, prodrugs, oncotumor gene therapy. Interestingly, it was originally suppressor genes) is the transduction of the appropriate observed that introduction of exogenous wt-p53 into nontarget cells. Tissue-specific methods for gene transfer or transformed, wt-p53 expressing cells, such as normal rat expression are being developed. Viral vectors are embryo fibroblasts, 16, 17 and VACO 235 adenoma cells 7 directed to target specific cell types through chimeric coat causes no observable phenotype, suggesting that the variproteins containing the viral env and eukaryotic ligands, ous effects induced by wt-p53 expression might occur such as EPO, 1 or by bi-specific molecular adaptors that only in tumor cells. recognize both env protein and cellular receptors. 2 It was observed that low-level UV irradiation can actiAnother strategy is based on inserting tissue-specific provate sequence-specific transcription by wt-p53 without an moters into retroviral long terminal repeats (LTRs). These increase in p53 protein levels. This activation can also be modifications drive exogenous gene transcription only in induced by antibodies specific to the C-terminal negative particular tissues. 3 An alternative approach to these straregulatory domain of p53 or by small peptides derived tegies might be offered by transduction of genes whose from this domain. It has thus been suggested that postexpression is detrimental only for tumor cells while not translational modifications of this negative regulatory harmful for normal ones. Some observations suggest that domain in vivo are rate-limiting steps for wt-p53 actithe p53 onco-suppressor might belong to this type of vation. 18, 19 Recently, we found that expression of temgene.
perature-sensitive p53 in its wild-type configuration Genetic modifications of the p53 onco-suppressor gene affects neither morphology nor proliferation of nontransare the most frequent alterations found in human canformed, murine 32D myeloid progenitors maintained in cers. [4] [5] [6] In the past few years, a large number of experitheir normal culture conditions. In contrast, an accelerments have been performed to study the suppressor ated apoptotic cell death was observed after IL-3 withactivities of exogenous wt-p53 expression in tumor cells drawal, 20 suggesting that this event might trigger the that have lost their normal alleles or bear p53 post-translational modifications that activate wt-p53, which would otherwise remain inactive in nonstressing conditions, in these nontransformed cells. However, directly activate wt-p53 in the absence of stressing conditions, or that they are no longer able to maintain wtp53 in an inactive form. We sought to take advantage of these findings for a new strategy of leukemia gene therapy. We proposed to purge the BM from leukemia by the functional targeting of tumor cells, while avoiding damage to normal ones, by delivering in vitro wt-p53 to all of the marrow cells. To begin to evaluate the feasibility of this strategy, we set up a series of experiments to verify whether the exogenous wt-p53 gene can be transduced into normal cells without untoward effects. Primary, murine BM cells were infected with two different recombinant retroviruses carrying the human wt-p53 cDNA and the puromycin (pBabe-p53) or the neomycin (pLp53SN) selectable markers. No differences in proliferation, differentiation, and colony formation in the presence of different cytokines were found between the infected and the control cells, indicating that normal murine BM cells can tolerate transduction of an exogenous wt-p53 gene. In contrast, the same wt-p53 expressing retroviruses were able to infect and induce a suppressing effect on 32Dv-src-transformed cells, suggesting the possibility of using a single agent to transduce both normal and tumor cells and obtain detrimental effects only in the latter.
Results
Expression of exogenous wt-p53 is not harmful to 32D myeloid progenitors The murine 32D cell line is constituted by nontumorigenic, myeloid progenitors, 22, 23 which are dependent on IL-3 for survival and proliferation, and differentiate into granulocytes upon granulocyte colony-stimulating factor (G-CSF) stimulation. 24 Because of these characteristics neither morphology nor proliferation of 32D cells maintained at a permissive temperature in their normal culture conditions. 20 To verify whether exogenous wt-p53 murine leukemia virus and carry the selectable markers expression is also compatible with differentiation, we for puromycin or neomycin resistance, respectively. The incubated the ts-p53-expressing 32D-tsp53#6 and 32D-murine ⍀E and GP+E packaging cells were transfected tsp53#10 cells 21 at the permissive temperature in the preswith the different constructs to produce ecotropic retroence of G-CSF, to assess their granulocyte maturation, viruses, as described in Materials and methods. compared with parental 32D cells. Granulocytic differenTo confirm that the human p53 protein produced by tiation was morphologically evaluated on cytocentrifuge our packaging cells has wild-type configuration, we preparations fixed and stained with May-Grunwald immunoprecipitated the exogenous p53 with mAbs Giemsa. No difference in differentiation was observed PAb1801 and PAb1620. The first mAb recognizes human between tsp53-expressing and control cells after 12 days p53 in both wild-type and mutant configurations while of incubation at 32°C in the presence of G-CSF (Figure the second recognizes only wild-type configuration. As 1). Thus, exogenous wt-p53 expression interferes neither shown in Figure 2 , both packaging cell lines -⍀E/Babewith morphology and proliferation, nor with differenp53 and GP+E/Lp53 -express an exogenous p53 protein tiation of 32D cells.
with wild-type immunoreactivity.
Mouse primary BM cells were infected by 24 h cocultivation with mitomycin-treated packaging cells in the Infection by retroviral vectors carrying wt-p53 does not affect the colony forming efficiency of primary BM cells presence of IL-3. The colony forming efficiency of these infected BM cells was tested by cultivation in methylThe results obtained with ts-p53 protein in 32D cells prompted us to evaluate the effects of exogenous wt-p53 cellulose, in the presence of IL-3, GM-CSF or EPO, and puromycin or G418 (see Materials and methods for transduction in primary BM cells. We inserted the human wt-p53 cDNA into two different retroviral vectorsdetails). As shown in Table 1 , cells infected with the wtp53 recombinant retroviruses form colonies with the pBabe-puro and pLXSN -which derive from Moloney same efficiency as those infected with the viruses carryp53-, control-and mock-infected cells (Figure 3a , EPO).
To confirm granulocytic-macrophage differentiation, the ing only the selectable markers. However, the number of colonies obtained from infected cells was only one-quarcapacity to phagocytose and reduce NBT was also assessed on cells infected with either LXSN or Lp53SN ter of the number obtained with mock-infected cells. To test whether this reduction in colony formation was due and grown in the presence of GM-CSF ( Figure 3b , upper panel). Fifty per cent of the colonies analyzed had NBTto low infection efficiency or to infection-mediated toxicity, BM cells were plated, after infection by LXSN or positive cells in both LXSN-and Lp53SN-infected populations. The percentage of NBT-positive cells was similar Lp53SN, in methylcellulose with IL-3 in the presence or absence of the selection drug G418. In the absence of in each colony analyzed independent of the virus used for the infection (Figure 3b , lower panel). Thus, infection G418 the number of colonies was similar between mockand retrovirus-infected cells indicating that the infection with wt-p53 recombinant retroviruses does not induce phenotypic changes, and does not affect in vitro colony per se is not toxic (data not shown).
To evaluate whether the infected cells that form coloformation and differentiation capacity of primary BM cells. nies in methylcellulose differentiate normally, cytospin preparations of single colonies were prepared and stained. May-Grunwald Giemsa staining was used to Detection of the exogenous wt-p53 gene in cell colonies The recombinant retroviruses used for BM cell infection assess cell morphology in the presence of IL-3 or GM-CSF. Typical BM monocytes with large cytoplasms carry the wt-p53 gene and the selection markers in the region comprised between the LTRs. However, to ascer- (Figure 3a , IL-3) and polymorphonuclear cells (Figure 3a , GM-CSF) were found in either uninfected and recombitain that our cells had integrated and expressed the exogenous wt-p53 gene, the presence of exogenous p53 nant retrovirus-infected cells. Benzidine reactivity was employed to verify erythroid differentiation in the prescDNA was verified on genomic DNA from single colonies grown in methylcellulose, by PCR amplification of ence of EPO. No differences were observed between wt- (Figure 4 , lower panel). The p53 cDNA was amplified from 25 of 32 colonies of Lp53SN-infected BM cells tested. Only in these 25 positive colonies was it also possible to amplify the endogenous cyclin-B1 gene as control (data not shown), indicating that seven colonies were p53 negative for PCR technical problems. Interestingly, a similar result was obtained from the colonies (10 of 10) grown in the absence of G418 selection suggesting that the reduction of colony formation observed after infection and selection (Table 1) is due to inefficient recombinant retrovirus gene expression rather than infection. Further studies are in progress better to clarify this issue.
Expression of exogenous wt-p53 protein was evaluated by indirect immunofluorescence on bulk-infected BM cells or on cell colonies grown in methylcellulose. In the first condition, the infected BM cells were selected for 2 days in puromycin-or G418-containing medium, separated from dead cells by density gradient centrifugation, and cytocentrifuged on to slides. For colony analysis, the colonies grown, after infection, in methylcellulose in the presence of IL-3, GM-CSF or EPO, and the selection drug, were recovered and cytocentrifuged. The cytospin preparations were fixed and reacted with anti-p53 mAb DO-1, which preferentially recognizes p53 of human origin. Expression of exogenous p53 was found both in bulkinfected and single-colony cells ( Figure 5A ). Moreover, exogenous p53 expression was confirmed in bulkinfected BM cells by Western blot analysis ( Figure 5B ).
Exogenous wt-p53-expressing BM cells can form spleen colonies The experiments described above indicate that BM cells can tolerate exogenous wt-p53 gene transduction when cultured in vitro. To verify whether these cells can survive and proliferate in vivo, we evaluated whether they maintained the capacity to produce spleen colonies. Sublethally irradiated F1-hybrid mice were injected with 5 × 10 5 syngeneic cells that had been mock-infected or infected with Babe-p53 or Babe-puro recombinant retroviruses. Ten days after injection, spleen colonies were dissected away from surrounding tissues, cultured in suspension for 2 days in the presence of IL-3 and puromycin, separated from dead cells by density gradient, and plated in methylcellulose in the presence of IL-3 and puromycin. No drug-resistant colonies grew from the mice injected The purpose of our study was to verify the absence of any phenotypic changes induced by exogenous wt-p53 expression in normal BM cells. To determine whether the lack of effect in normal cells was due to the capacity of these cells to tolerate transduction of the exogenous wt-DNA sequences corresponding to p53 exons 7 and 8. The two primers used for PCR encompass a 288-bp fragment p53 gene, rather than to an alteration in the protein encoded by our recombinant retroviruses, we sought to infect of p53 cDNA. This fragment was amplified only in the colonies derived from BM cells infected with the retroparental 32D and 32Dv-src-transformed cells to ascertain exogenous wt-p53 activity. We had already shown that viruses carrying the wt-p53 gene (Figure 4, upper panel) . Southern blot hybridization was performed with a p53 exogenous wt-p53 expression in 32D cells accelerates apoptosis upon IL-3 withdrawal 20 while in 32Dv-srcprobe to confirm the specificity of the amplified products Figure 2. transformed cells it induces monocytic differentiation temperature, 20 acceleration of apoptosis was found in the Lp53SN-infected 32D cells compared with LXSN-infected without affecting cell viability and proliferation rates. 21 Thus, 32D and 32Dv-src cells were infected with LXSN control (Figure 6c ). Monocytic differentiation of 32Dv-src cells was perforor Lp53SN, and selected in G418-containing media. To verify whether exogenous p53 protein was in wild-type med by the ␣-naphthyl esterase lympho-monocytic marker. Approximately 20% of exogenous wt-p53-configuration, 32Dv-src-infected cells were lysed and p53 protein was immunoprecipitated by mAbs PAb240, expressing cells were positive for ␣-naphthyl esterase (data not shown), as already reported for ts-p53-expresswhich recognizes mutant p53, or PAb1620, which recognizes wt-p53. As shown in Figure 6a , only PAb1620 was ing and pBabe-p53-infected 32Dv-src cells. 21 Thus, p53 protein encoded by our recombinant retroviruses is in able to precipitate the exogenous p53 protein indicating that it is expressed in 32Dv-src cells and is in wild-type wild-type configuration and is able to induce biological effects in the appropriate conditions (ie growth factor configuration. To verify whether exogenous p53 protein was correctly localized in the nucleus, 32D-infected cells withdrawal in nontransformed cells, or expression in tumor cells). were analyzed by indirect immunofluorescence. As shown in Figure 6b , fluorescence was mostly present in the nuclei, as expected for wt-p53 protein. The apoptotic Discussion rate of 32D cells after IL-3 withdrawal was evaluated by the trypan blue exclusion test. As reported for ts-p53-We evaluated the effects induced by infection with wtp53 recombinant retroviruses in nontransformed, expressing 32D cells maintained at the permissive Moreover, preliminary in vivo experiments indicate that wt-p53 retrovirus-infected BM cells injected i.v. in sublethally irradiated mice can produce puromycin-resistant spleen colonies. In contrast, infection of nontransformed 32D and transformed 32Dv-src cells by the same retroviruses induced acceleration of apoptosis upon IL-3 withdrawal and monocytic differentiation, respectively, as already observed after ts-p53 overexpression at the permissive temperature. 20, 21 Taken together, these results strongly indicate that transduction of wt-p53 is not harmful for normal cells in the absence of stressing stimuli, whereas it has a suppressor activity on tumor cells.
Figure 4 PCR analysis of transduced p53 cDNA. Primary uninfected bone marrow cells (BM), or bone marrow cells infected with Babe-puro (puro), LXSN, Babe-p53 (p53), or Lp53SN were plated in methylcellulose in the presence of the indicated cytokines. Upper panel: cells from single colonies were processed for amplification of a human p53 sequence of 288 bp. Lower panel: Southern blot hybridization of the gel shown in the upper panel with a p53 probe. SV-p53 is a plasmid carrying the entire human p53 cDNA that was used as positive control.

Figure 5 Exogenous wt-p53 expression in BM cells. (A) Cytocentrifuge preparations were obtained with the following cells: BM cells infected with Babe-p53 (a, b, e and f), BM cells infected with Babe-puro (c, d, g and h). a, b, c and d are cells maintained as bulk population; e, f, g and h are individual colonies grown in methylcellulose. The cells were fixed and permeabilized, and exogenous human p53 was detected by indirect immunofluorescence with mAb DO-1 (a, c, e and g); b, d, f and h are the relative phase-contrast fields. (B) BM cells infected with LXSN or Lp53SN and maintained as a bulk population were lysed, run on 10% SDS-PAGE, blotted, and reacted with Ab7 polyclonal p53 anti-serum, as described in
It was previously observed that infection by wt-p53 recombinant adenovirus of a nontransformed fibroblast cell line or normal human bronchial epithelial cells in vitro, or normal lung cells in vivo, does not modify the in vitro cell proliferation rate, and is not toxic in vivo for the lung. [26] [27] [28] [29] Our data extend these observations in a cell system -the hematopoietic one -whose homeostasis is regulated by a precise balance of proliferation, apoptosis and differentiation. They might open the way to BM purging from leukemias by p53 gene delivery without the need to target specifically and uniquely the tumor cells. Indeed, on the basis of our data, it can be speculated that infection of both normal BM and leukemic cells should result in survival of the normal cells and suppression of tumorigenicity of the leukemic ones. This approach will probably require a higher efficiency of transduction/expression than the 25% we obtained in our drug-selected cells. We are currently trying different infection protocols in the presence of different cytokines. Moreover, in vivo BM reconstitution experiments are in progress to verify the complete safety of exogenous wtp53 expression.
The molecular mechanisms underlying the different responses to wt-p53 expression of normal versus tumor cells are unknown. It has been recently shown that in normal fibroblasts, upon induction of DNA damage, p53 is able to bind DNA even in the absence of increased protein levels, 18, 19 indicating that p53 is present in normal cells in an inactive form. We previously showed that wtp53 overexpression induced no effects in nontransformed 32D cells when they were incubated in the presence of the appropriate growth factors. In contrast, an accelerated apoptotic rate was observed in the same cells after IL-3 withdrawal. 20 These results suggested that nontransfor- Another possible divergence between normal and transformed cells in exogenous wt-p53 regulation might be due to its degradation. Normal cells might be more active myeloid 32D progenitors and primary BM cells. We found that transduction of the wt-p53 gene does not affect in degrading exogenous p53 protein than their transformed counterparts. The two mechanisms are not mutually morphology, proliferation, and differentiation capacity of both 32D and primary BM cells, as long as they are mainexclusive. Understanding the molecular mechanisms that determine the different responses of normal and tumor tained in the presence of growth or differentiation factor supplies (IL-3, G-CSF, GM-CSF or EPO and serum).
cells to wt-p53 expression will likely help in developing new gene therapy approaches based on the onco-supPolymerase chain reaction (PCR) PCR amplification was performed on cell lysates using a pressor p53 gene.
PCR kit (Perkin Elmer Cetus, Norwalk, CT, USA), following the manufacturer's instructions. Single colonies
Materials and methods
derived from methylcellulose cultures were isolated with a micropipette, lysed in 50 l of lysis buffer (10 mm Tris-
Cell cultures
HCl pH 8; 0.5 mm EDTA; 0.0001% SDS; 0.01% Triton Parental 32Dcl.3 murine hematopoietic progenitors and X100; 100 g/ml proteinase K), incubated for 1 h at 55°C, their derivatives 32D-tsp53#6 and 32D-tsp53#10, which and used in a 100 l PCR reaction after proteinase K heat express the temperature-sensitive p53Val 135 mutant, 21 inactivation. A fragment of 288 bp, corresponding to were cultured in RPMI-1640 medium (BIO-Whittaker, parts of exons 7 and 8, was amplified using a 5′ primer Walkersville, MD, USA) supplemented with 10% heatcomplementary to exon 7 5′(TAGTGTGGTGGT inactivated fetal bovine serum (FBS) (GIBCO BRL, Life GCCCTATGAGCCG)3′, and a 3′ primer complementary Technology, Grand Island, NY, USA), 5% conditioned to exon 8 3′(CCTCGTGATTCGCTCGTGACGGGTT)5′. medium from the murine myelomonocytic cell line Samples of 10 l from each PCR reaction were visualized WEHI-3B as a source of crude IL-3 (IL-3/CM), 30 and genon 1.5% agarose gel by ethidium-bromide staining. The tamicin (BIO-Whittaker). WEHI-3B and 32Dv-src cells 21 amplification specificity was controlled by blotting the were cultured in RPMI-1640 with 10% FBS. ⍀E 31 and PCR products on to nylon membranes and hybridizing GP+E 32 ecotropic packaging cell lines were cultured in with the human p53 cDNA by standard procedures. DMEM medium (BIO-Whittaker) supplemented with 10% FBS.
Indirect immunofluorescence Approximately 4 × 10 4 cells were spun on to a glass slide Retroviral vectors and packaging cells with a cytocentrifuge. Cytospin preparations were airThe construction of pBabe-puro and pLXSN retroviral dried, fixed with 2% formaldehyde for 10 min at room vectors has been described. 31, 33 Briefly, pBabe-puro and temperature (RT), permeabilized with 0.1% Triton X100 pLXSN are defective Moloney murine leukemia virusfor 1 min, blocked for 30 min at RT in PBS, containing based vectors containing, respectively, the bacterial puro 3% FBS and incubated for 1 h at 37°C with mAb DO-1 or neo gene downstream of the SV40 early promoter. The (Ab-6 from Oncogene Science, Uniondale, NY, USA), pBabe-p53 and pLp53SN vectors were obtained by which reacts preferentially with human p53 protein.
34
inserting the human wt-p53 cDNA, derived from After washing, cytospins were incubated for 45 min at pCMVp53, 7 into the unique BamHI site of pBabe-puro 37°C with biotin-conjugated goat anti-mouse IgG (Pierce and pLXSN vectors.
Europe, Oud Beijerland, The Netherlands), and subVirus-producing cell lines were generated by stable sequently incubated for 45 min at 37°C with fluoresceintransfection of ⍀E and GP+E ecotropic packaging cells conjugated streptavidin (Becton Dickinson, Cedex FR). with the retroviral vectors. Vector DNAs were transfected into ⍀E and GP+E cells by calcium-phosphate preMorphological and differentiation analyses cipitation. Selection of stably transfected mixed popuApproximately 4 × 10 4 cells cultured in suspension, or lations was performed with 2 g/ml of puromycin or 1.5 cells derived from single colonies grown in methylcellumg/ml of G418 for 2 weeks. Retroviral titrations were lose, were spun on to glass slides with a cytocentrifuge. performed as described. 31 For morphological analysis, cytospin preparations were fixed and stained with May-Grunwald Giemsa (Sigma,
Retroviral infections
St Louis, MO, USA) and observed with a light microPrimary BM cells were obtained from the long bones of scope. To evaluate granulocytic-macrophage differendead C57Bl/6 mice. Approximately 1 × 10 6 BM cells were tiation of bone marrow cells the ability to phagocyte and incubated for 1 h with 8 g/ml polybrene and then reduce nitroblue tetrazolium (NBT) was measured. Single infected in IL-3-containing medium by in vitro coculticolonies were resuspended in 100 l of RPMI and then vation with 1 × 10 6 mitomycin-treated, retrovirus producreacted with 100 l of NBT solution (Sigma), as ing packaging cells. After 16 h of cocultivation, BM cells described. 15 NBT positivity was determined on Maywere removed from the packaging monolayer and Grunwald Giemsa-stained cytospins observed with a replated in fresh IL-3-containing medium. After a further light microscope. For evaluation of erythroid differen-24 h, BM cells were assayed for in vitro colony formation.
tiation, the cells were reacted with benzidine as described, 35 before cytocentrifugation. Positive blue Colony formation stained cells were observed with a light microscope. Infected BM cells (1 × 10 5 ) were suspended in 2 ml of methylcellulose culture mixture (Stemcell Technologies, Spleen colony formation c/o Terry Fox Laboratory, Vancouver, Canada), in the Primary BM cells were obtained from DBA-2 mice prepresence of IL-3, GM-CSF or EPO, and 2 g/ml puromytreated with 5-FU (150 mg/kg i.v. 48 h before harvesting cin or 1.5 mg/ml G418, and plated into two 35-mm Petri BM cells) and infected as described above. Infected cells dishes. Optimal cytokine concentrations were determined were selected for 48 h in the presence of puromycin. Live by dose-response colony formation assays: 10% of ILcells were separated from dead ones by density gradient, 3/CM; 10 U/ml of recombinant m-EPO (Boehringerand injected i.v. (5 × 10 5 per mouse) in sublethally XMannheim Italia, Milan, Italy), plus 5% IL-3/CM; 1.63 irradiated (6 Gy) DBA-2 mice. U/ml of recombinant m-GM-CSF (Genetics Institute, Cambridge, MA, USA). After 12 days of incubation, BM Immunoprecipitation and Western blotting Approximately 1 × 10 6 ⍀E and GP+E ecotropic packaging colonies were counted under an inverted microscope and analyzed for morphology and exogenous p53 expression.
cell lines were incubated for 30 min on ice in lysis buffer
